In general, this also shows that phytocannabinoids have non-cannabinoid receptor interactions and therefore could be relevant for regulating diabetes through multiple mechanisms, with benefits in SGLT2 regulation. This evidence concerns the gene SLC5A2 and diabetes mellitus.